Suppr超能文献

异体骨软骨移植与自体骨软骨移植治疗距骨软骨缺损:系统评价和荟萃分析。

Allograft Versus Autograft Osteochondral Transplant for Chondral Defects of the Talus: Systematic Review and Meta-analysis.

机构信息

Department of Orthopedic, Trauma, and Reconstructive Surgery, RWTH Aachen University Hospital, Aachen, Germany.

Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi, Italy.

出版信息

Am J Sports Med. 2022 Oct;50(12):3447-3455. doi: 10.1177/03635465211037349. Epub 2021 Sep 23.

Abstract

BACKGROUND

It is unclear whether the results of osteochondral transplant using autografts or allografts for talar osteochondral defect are equivalent.

PURPOSE

A systematic review of the literature was conducted to compare allografts and autografts in terms of patient-reported outcome measures (PROMs), MRI findings, and complications.

STUDY DESIGN

Systematic review; Level of evidence, 4.

METHODS

This study was conducted according to the PRISMA guidelines. The literature search was conducted in February 2021. All studies investigating the outcomes of allograft and/or autograft osteochondral transplant as management for osteochondral defects of the talus were accessed. The outcomes of interest were visual analog scale (VAS) score for pain, American Orthopaedic Foot and Ankle Society (AOFAS) score, and Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score. Data concerning the rates of failure and revision surgery were also collected. Continuous data were analyzed using the mean difference (MD), whereas binary data were evaluated with the odds ratio (OR) effect measure.

RESULTS

Data from 40 studies (1174 procedures) with a mean follow-up of 46.5 ± 25 months were retrieved. There was comparability concerning the length of follow-up, male to female ratio, mean age, body mass index, defect size, VAS score, and AOFAS score ( > .1) between the groups at baseline. At the last follow-up, the MOCART (MD, 10.5; = .04) and AOFAS (MD, 4.8; = .04) scores were better in the autograft group. The VAS score was similar between the 2 groups ( = .4). At the last follow-up, autografts demonstrated lower rate of revision surgery (OR, 7.2; < .0001) and failure (OR, 5.1; < .0001).

CONCLUSION

Based on the main findings of the present systematic review, talar osteochondral transplant using allografts was associated with higher rates of failure and revision compared with autografts at midterm follow-up.

摘要

背景

使用自体移植物或同种异体移植物治疗距骨骨软骨缺损的结果是否相当仍不清楚。

目的

对文献进行系统回顾,比较同种异体移植物和自体移植物在患者报告的结局测量(PROMs)、MRI 结果和并发症方面的差异。

研究设计

系统回顾;证据水平,4 级。

方法

本研究按照 PRISMA 指南进行。文献检索于 2021 年 2 月进行。检索了所有研究同种异体和/或自体骨软骨移植作为距骨骨软骨缺损治疗的结果。感兴趣的结局包括疼痛的视觉模拟量表(VAS)评分、美国矫形足踝协会(AOFAS)评分和磁共振软骨修复组织观察(MOCART)评分。还收集了失败和翻修手术的发生率数据。连续数据采用均数差(MD)进行分析,二分类数据采用比值比(OR)效应量进行评估。

结果

共纳入 40 项研究(1174 例手术),平均随访 46.5±25 个月。两组在随访时间、男女比例、平均年龄、体重指数、缺损大小、VAS 评分和 AOFAS 评分方面具有可比性(>.1)。末次随访时,自体移植物组的 MOCART(MD,10.5; =.04)和 AOFAS(MD,4.8; =.04)评分更高。两组 VAS 评分相似( =.4)。末次随访时,自体移植物组的翻修手术(OR,7.2; <.0001)和失败(OR,5.1; <.0001)发生率较低。

结论

基于本系统综述的主要发现,同种异体移植物治疗距骨骨软骨缺损与自体移植物相比,在中期随访时失败和翻修的发生率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21c7/9527449/a6cfb11e74d2/10.1177_03635465211037349-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验